Original language | English (US) |
---|---|
Pages (from-to) | e41-e44 |
Journal | British Journal of Haematology |
Volume | 196 |
Issue number | 5 |
DOIs | |
State | Published - Mar 2022 |
Keywords
- Clinical
- Sickle Cell Anemia
- Sickle Cell Disease
ASJC Scopus subject areas
- Hematology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: British Journal of Haematology, Vol. 196, No. 5, 03.2022, p. e41-e44.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Frequent health care utilisation and avascular necrosis are associated with cannabis use in adults with sickle cell disease
AU - Miodownik, Hope
AU - Curtis, Susanna A.
AU - Olivia Ogu, Ugochi
AU - Bradford, Christopher
AU - Starrels, Joanna L.
AU - Cunningham, Chinazo O.
AU - Arnsten, Julia H.
AU - Choi, Jaeun
AU - Eisenberg, Ruth E.
AU - Minniti, Caterina P.
N1 - Funding Information: Dr Curtis is supported by K23HL151884, Dr Cunningham is supported by K24DA036955, Dr Starrels is supported by K24DA046309, and Drs Starrels, Cunningham, and Arnsten are supported by R01DA044171. Funding Information: Drs Miodownik, Bradford, Cunningham, Arnsten, Choi, and Eisenberg report no conflicts of interest or competing interests. Dr Curtis declares consultancy for Global Blood Therapeutics. Dr Ogu declares Consultancy for Vertex Pharmaceuticals and Novo‐Nordisk, Speaker Bureau for Global Blood Therapeutics. Dr Minniti declares Advisory roles to Novartis, Global Blood Therapeutics, Roche, Forma, Bluebird Bio, Emmaus Life Science, CSL‐ Behring, Chiesi, Novo‐Nordisk and Research support from Global Blood Therapeutics and Bayer. Dr Starrels declares research support from the FDA‐mandated Opioid Post‐Marketing Requirement Consortium.
PY - 2022/3
Y1 - 2022/3
KW - Clinical
KW - Sickle Cell Anemia
KW - Sickle Cell Disease
UR - http://www.scopus.com/inward/record.url?scp=85117193954&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117193954&partnerID=8YFLogxK
U2 - 10.1111/bjh.17901
DO - 10.1111/bjh.17901
M3 - Letter
C2 - 34661288
AN - SCOPUS:85117193954
SN - 0007-1048
VL - 196
SP - e41-e44
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 5
ER -